Want to join the conversation?
The generic drugmaker $MYL reported a fall in 3Q15 earnings due to higher operating expenses and tax benefit recorded in the previous year quarter on merger of its units into Mylan Labs. Net earnings fell to $428.6MM or $0.83 per share from $499.1MM or $1.26 per share last year. Revenue grew to $2.7Bil from $2.08Bil. Adjusted EPS grew 23% to $1.43.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.